IceCure Medical Ltd

NASDAQ: ICCM · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: May 23, 2025, 3:59 PM
1.06
1.40%
After-hours: May 23, 2025, 07:34 PM EDT

IceCure Medical Ltd Statistics

Share Statistics

IceCure Medical Ltd has 56.57M shares outstanding. The number of shares has increased by 18% in one year.

Shares Outstanding 56.57M
Shares Change (YoY) 18%
Shares Change (QoQ) 3.27%
Owned by Institutions (%) 0.31%
Shares Floating n/a
Failed to Deliver (FTD) Shares 7,884
FTD / Avg. Volume 2.99%

Short Selling Information

The latest short interest is 240.29K, so 0.41% of the outstanding shares have been sold short.

Short Interest 240.29K
Short % of Shares Out 0.41%
Short % of Float 4.91%
Short Ratio (days to cover) 1.43

Valuation Ratios

The PE ratio is -3.65 and the forward PE ratio is -6.73. IceCure Medical Ltd's PEG ratio is 1.17.

PE Ratio -3.65
Forward PE -6.73
PS Ratio 17.01
Forward PS 0.7
PB Ratio 8.11
P/FCF Ratio -4.43
PEG Ratio 1.17
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for IceCure Medical Ltd.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.07.

Current Ratio 1.95
Quick Ratio 1.59
Debt / Equity 0.07
Debt / EBITDA -0.03
Debt / FCF -0.04
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $51,421.88
Profits Per Employee $-239,343.75
Employee Count 64
Asset Turnover 0.26
Inventory Turnover 0.93

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 0.97% in the last 52 weeks. The beta is 2.7, so IceCure Medical Ltd's price volatility has been higher than the market average.

Beta 2.7
52-Week Price Change 0.97%
50-Day Moving Average 1.15
200-Day Moving Average 0.97
Relative Strength Index (RSI) 47.02
Average Volume (20 Days) 264,096

Income Statement

In the last 12 months, IceCure Medical Ltd had revenue of 3.29M and earned -15.32M in profits. Earnings per share was -0.31.

Revenue 3.29M
Gross Profit 1.45M
Operating Income -15.7M
Net Income -15.32M
EBITDA -15.36M
EBIT -15.7M
Earnings Per Share (EPS) -0.31
Full Income Statement

Balance Sheet

The company has 7.56M in cash and 459K in debt, giving a net cash position of 7.11M.

Cash & Cash Equivalents 7.56M
Total Debt 459K
Net Cash 7.11M
Retained Earnings -105.38M
Total Assets 12.58M
Working Capital 5.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.56M and capital expenditures -71K, giving a free cash flow of -12.63M.

Operating Cash Flow -12.56M
Capital Expenditures -71K
Free Cash Flow -12.63M
FCF Per Share -0.25
Full Cash Flow Statement

Margins

Gross margin is 44.09%, with operating and profit margins of -476.94% and -465.45%.

Gross Margin 44.09%
Operating Margin -476.94%
Pretax Margin -465.45%
Profit Margin -465.45%
EBITDA Margin -466.85%
EBIT Margin -476.94%
FCF Margin -383.9%

Dividends & Yields

ICCM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ICCM is $2.5, which is 140.4% higher than the current price. The consensus rating is "Buy".

Price Target $2.5
Price Target Difference 140.4%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Aug 9, 2021. It was a backward split with a ratio of 1:8.

Last Split Date Aug 9, 2021
Split Type backward
Split Ratio 1:8

Scores

Altman Z-Score -8.99
Piotroski F-Score 3